logo-loader
Arcadia Biosciences Inc

Arcadia Biosciences rises as company says it's well-positioned to apply expertise to cannabis

A new business unit, Arcadia Specialty Genomics, is dedicated to improving the plant quality, productivity, consistency and climate resilience of cannabis

Hemp plants
The move to cannabis reflects the 'natural evolution' of business, according to Arcadia

Arcadia Biosciences Inc (NASDAQ:RKDA) climbed in Wednesday’s extended trading after saying it’s well-positioned to apply its expertise to cannabis.

The food ingredient company said a new business unit, Arcadia Specialty Genomics, is dedicated to improving the plant quality, productivity, consistency and climate resilience of cannabis, working initially in hemp in legal markets.

Shares of Arcadia advanced 3.5% to $7.20 in after-hours trading.

READ: Arcadia Biosciences shares soar after FDA approves GLA safflower oil in cat food

“This is a natural evolution of our business, consistent with Arcadia’s focus as a consumer-driven agricultural technology company, developing and commercializing innovative food ingredients, nutritional oils and products that improve crop productivity, nutritional quality and value,” Arcadia CEO Raj Ketkar said in a statement.

Looking back at 2018, the Davis, California, company delivered significant regulatory, commercial and scientific advancements in wheat, soy, tomato and safflower, according to Ketkar.

Highlights for the year included the granting of a US patent for technology that extends the storage life of whole-wheat flour by minimizing oxidation.

The company reported that the net loss attributable to common stockholders for the fourth quarter was $646,000, or $0.14 per share, compared with a loss of $3 million loss a year earlier.

The net loss attributable to common stockholders for 2018 was $13.5 million, or a loss of $3.58 per share, compared with the $15.7 million loss in 2017.

Contact Dennis Fitzgerald at [email protected]

Quick facts: Arcadia Biosciences Inc

Price: $5.77

Market: NASDAQ
Market Cap: $42.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

on 08/16/2019

2 min read